Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: argenx SE

Market Cap 4.87TCr 5.64TCr 4.49TCr 4.2TCr 7.88TCr 5,36300Cr 8TCr 53TCr 21TCr 2,61000Cr 21TCr 21TCr 9,03800Cr P/E Ratio 2026 *
33.2x
P/E Ratio 2027 * 25.1x
Enterprise Value 4.41TCr 5.11TCr 4.07TCr 3.81TCr 7.14TCr 4,85800Cr 7.25TCr 48TCr 19TCr 2,36500Cr 19TCr 19TCr 8,18700Cr EV / Sales 2026 *
8.64x
EV / Sales 2027 * 6.77x
Free-Float
100%
Yield 2026 *
0.05%
Yield 2027 * 0.11%
1 day-1.63%
1 week+1.00%
Current month+7.71%
1 month+11.19%
3 months+24.97%
6 months+6.52%
Current year+7.53%
1 week 749
Extreme 749
787
1 month 661.4
Extreme 661.4
787
Current year 568.4
Extreme 568.4
787
1 year 456.6
Extreme 456.6
810
3 years 271
Extreme 271
810
5 years 224.1
Extreme 224.1
810
10 years 10.55
Extreme 10.55
810
Manager TitleAgeSince
Chief Executive Officer 47 06/05/2026
Director of Finance/CFO 56 01/06/2021
Chief Tech/Sci/R&D Officer - 01/01/2015
Director TitleAgeSince
Director/Board Member 72 26/04/2017
Director/Board Member 76 13/05/2015
Director/Board Member 65 28/04/2016
Date Insider Type Main position Quantity % Market Cap.
23/11Fiscal year

Director

4,680 0.0076%
23/11Fiscal year

Chief Executive Officer

2,000 0.0032%
23/11Sell

Director

4,680 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
-1.58%+1.00%+59.55%+113.64% 5.64TCr
+2.72%+3.26%+46.05%+47.37% 4.45TCr
+1.12%+2.79%-15.04%-18.40% 2.29TCr
+1.17%+3.85%-0.89%+407.26% 2.12TCr
-0.51%+1.78%+16.68%-34.63% 1.64TCr
-0.02%+0.25%+9.53%-38.48% 1.54TCr
-0.69%+0.82%+27.75%+182.91% 1.34TCr
+0.96%+9.74%+17.55% - 1.24TCr
+1.61%+1.28%+95.75%+206.59% 1.12TCr
+1.37%-1.28%+62.66%+87.28% 1.11TCr
Average +0.61%+1.75%+31.96%+105.95% 2.25TCr
Weighted average by Cap. +0.47%+2.19%+34.78%+100.22%

Financials

2026 *2027 *
Net sales 510.68Cr 591.27Cr 470.59Cr 440.5Cr 825.52Cr 56TCr 838.3Cr 5.56TCr 2.17TCr 27TCr 2.22TCr 2.17TCr 95TCr 621.11Cr 719.12Cr 572.35Cr 535.75Cr 1TCr 68TCr 1.02TCr 6.76TCr 2.63TCr 33TCr 2.7TCr 2.64TCr 1,15200Cr
Net income 150.67Cr 174.45Cr 138.84Cr 129.96Cr 243.56Cr 17TCr 247.33Cr 1.64TCr 639.2Cr 8.07TCr 654.71Cr 640.77Cr 28TCr 206.77Cr 239.4Cr 190.54Cr 178.36Cr 334.25Cr 23TCr 339.43Cr 2.25TCr 877.2Cr 11TCr 898.49Cr 879.36Cr 38TCr
Net Debt -458.71Cr -531.1Cr -422.7Cr -395.67Cr -741.51Cr -50TCr -752.99Cr -4.99TCr -1.95TCr -25TCr -1.99TCr -1.95TCr -85TCr -669.33Cr -774.96Cr -616.79Cr -577.34Cr -1.08TCr -74TCr -1.1TCr -7.28TCr -2.84TCr -36TCr -2.91TCr -2.85TCr -1,24100Cr
Logo argenx SE
argenx SE is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx SE aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx SE developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises.
Employees
1,863
Date Price Change Volume
15/26/15 771.20 -1.58% 10,043
12/26/12 783.60 +1.03% 88,275
11/26/11 775.60 +1.65% 69,409
10/26/10 763.00 +0.66% 78,185
09/26/09 758.00 -0.68% 82,273
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
783.60EUR
Average target price
846.68EUR
Spread / Average Target
+8.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARGX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!